Navigation Links
Thomson Reuters Trademark Report Reveals New Challenges and Opportunities for Pharmaceutical Brands
Date:6/8/2011

NEW YORK, June 8, 2011 /PRNewswire/ -- According to a report published today by Thomson CompuMark, part of Thomson Reuters, the pharmaceutical industry has begun to adapt to stricter governmental brand name standards globally by rapidly increasing the number of trademarks it files for every new drug. These newer standards by the U.S. Food and Drug Administration (FDA) and European Medicines Agency (EMA) are part of an effort to prevent look-alike/sound-alike pharmaceutical brand names and have led to increased rejection rates of new drug names.

The special report, Pharmaceutical Trademarks: How to Survive the Name Game – New Challenges and Opportunities for Pharmaceutical Companies, tracks trends in pharmaceutical trademark activity over the last 30 years, incorporates input from leading trademark attorneys and pharmaceutical industry executives and analyzes trademark initiatives at the FDA and EMA to shed light on this critical issue. Following are some of the key observations in the analysis:

  • FDA and EMA Rejection Rates Up: The long-term FDA trademark rejection rate is 30%, but it has increased to approximately 36% in recent years as the organization has adopted a more stringent approach to brand approvals. Combined, the FDA and EMA are rejecting 40%-50% of pharmaceutical trademarks each year.

  • More than 300% Increase in Global Pharma Trademark Filings: Between 1980 and 2010, the number of pharmaceutical trademarks filed increased by more than 300%. A total of 238,010 pharmaceutical trademarks were filed globally in 2010.

  • China Filing Most Pharmaceutical Trademarks in 2010: Chinese firms filed 36,105 pharmaceutical trademarks in 2010, more than any other region globally. China was followed by the US (27,545) and India (26,123). Some surprise emerging markets such as Vietnam, Venezuela and Turkey were also among the top 10 countries filing the most drug trademarks in 2010.

  • FDA Pilot Program Paves Way to Industry Best Practices: The FDA has initiated an industry-wide pilot program designed to improve consumer safety, streamline the review process and make regulatory decisions more transparent. By fostering collaboration with the pharmaceutical industry, this program has led to the development of several best practices that will contribute to the standardization of the trademark process.

"Pharmaceutical companies are facing more hurdles than ever to get new drugs to market, but, in the long run, the steps they are taking now to adapt to the new regulatory reality will improve safety and efficiency in the marketplace," said Martin Burke, managing director of Thomson CompuMark. "The key to that transition will be giving stakeholders access to the information they need to make informed decisions. We will continue to help the process by developing analytics that help brand owners reduce risk by properly vetting new trademark names on a global basis."

This report was compiled using Thomson CompuMark data to identify trends in pharmaceutical trademark applications and top filers by company and country. Thomson CompuMark Pharma Search reports allow pharmaceutical brand owners and their legal teams to screen trademark names globally, across different sources to review critical information quickly and efficiently, identifying potentially troublesome naming constructs before they ever become a hindrance to the new drug approval process.

To view the full report, Pharmaceutical Trademarks: How to Survive the Name Game – New Challenges and Opportunities for Pharmaceutical Companies go to: http://compumark.thomson.com/do/pharma_special_report.

Thomson Reuters

Thomson Reuters is the world's leading source of intelligent information for businesses and professionals. We combine industry expertise with innovative technology to deliver critical information to leading decision makers in the financial, legal, tax and accounting, healthcare and science and media markets, powered by the world's most trusted news organization. With headquarters in New York and major operations in London and Eagan, Minnesota, Thomson Reuters employs more than 55,000 people and operates in over 100 countries. For more information, go to http://thomsonreuters.com.


'/>"/>
SOURCE Thomson Reuters
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Drug Combinations That May Cause Major Drug Interactions Common Among Seniors Who Take Antidepressants, According to Thomson Reuters Research
2. Higher Education Foundation in Brazil Seals Its Continued Relationship with Thomson Reuters for Academic Healthcare Content
3. Asia Pacific Pharma Companies Turning to High-Risk, High-Reward Drug Development, According to New Report from Thomson Reuters
4. Thomson Reuters Unveils Pharmacy Xpert Solution to Improve Medication Management for Hospital Pharmacists
5. Thomson Reuters Releases iPhone Support for Clinical Xpert Navigator
6. Federal Government Selects Thomson Reuters to Build Tool That Streamlines Comparative Effectiveness Research
7. Thomson Reuters Predicts Nobel Laureates
8. Morehead Memorial Hospital Goes Live with Thomson Reuters Clinical Xpert CareFocus
9. Thomson Reuters Expands CareNotes® Patient Education System to Support 15 Languages
10. Americans Confidence in Their Ability to Access and Pay for Healthcare Declines Significantly in May, According to Thomson Reuters Index
11. Global Pharmaceutical R&D Productivity Declining According to Thomson Reuters, CMR International
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2017)... , Sept. 22, 2017 AVACEN Medical ... device is now successfully helping those with the widespread ... Fibromyalgia diagnosed Amanda in Essex, England ... and washing my hair, experiencing no sleep at all, ... painful spasm… I cannot recommend [the AVACEN 100] enough, ...
(Date:9/18/2017)... 18, 2017 EpiVax, Inc. ("EpiVax") ... and immune engineering, today announced a new ... (H7N9) vaccine. ... influenza and presents a challenge for traditional ... to be effective. Using state-of-the-art bioinformatics and molecular ...
(Date:9/12/2017)... 2017  ValGenesis Inc., the global leader in ... to announce the appointment of Dr. Ajaz ... of Directors and Chairman of Advisory Board beginning ... companies to manage their entire validation lifecycle process ... this process. Furthermore, ValGenesis VLMS enables rigorous compliance, ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... 13, 2017 , ... Ellevate Network, the leading network for professional women, brought ... gender equality at their inaugural Summit in New York City in June. The event ... audience of over 3 million. To watch the Mobilize Women video, click here ...
(Date:10/13/2017)... ... ... “The Journey: From the Mountains to the Mission Field”: the story of ... Philippines. “The Journey: From the Mountains to the Mission Field” is the creation of ... taught all ages and currently teaches a class of ladies at her church, which ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... meet the demand of today’s consumer and regulatory authorities worldwide. From Children’s to ... and tested to meet the highest standard. , These products are also: ...
(Date:10/12/2017)... ... October 12, 2017 , ... Dr. Parsa ... contributed a medical article to the newly revamped Cosmetic Town journal ... the hair transplant procedure known as Follicular Unit Extraction (FUE). , ...
(Date:10/12/2017)... ... , ... Health Literacy Innovations (HLI), creator of the Health ... Cancer Patient Education Network (CPEN), an independent professional organization that shares best practices ... , As CPEN’s strategic partner, HLI will help support CPEN members by ...
Breaking Medicine News(10 mins):